Virtual-Endoscopic Reporter for Lung-Cancer Assessment

Project: Research project

Project Details


DESCRIPTION (Provided by Applicant): To improve the care of lung-cancer
patients, we propose to prototype a computer-based multimedia reporting system.
This system, dubbed the 3D Reporter, will enable a physician to construct a
multimedia case report of a patient's three-dimensional (3D) X-ray
computer-tomography (CT) chest scan. The 3D Reporter draws upon recent
innovations in virtual endoscopy, image processing, and computer graphics. This
Phase-I project's aims are as follows: (1) prototype the 3D Reporter's main
interactive visualization system; (2) devise a 3D path-planning tool that helps
build a case report with the interactive system; and (3) conceive the Phase-Il
proposal and product development plan. Early efforts assert the basic
technology's utility for 3D CT assessment and bronchoscopic procedure planning.
The proposed 3D Reporter could enable much easier and more complete 3D CT image
assessment. Also, the multimedia report generated by the 3D Reporter could
provide useful guidance during bronchoscopic interventions, such as
transbronchial needle aspiration, stent design, and laser ablation. in the long
run, the proposed system could have further use for complete early detection,
staging, diagnosis and treatment of lung cancer. Also, specific protocols and
products could be designed for stent design, lymph-node biopsy, solitary
cancer-nodule treatment, and mediastinoscopy.
Lung Cancer is the leading cause of cancer death. This is true, despite the existence of
early assessment devices such as high-resolution 3D computer-tomography (CT) scanners
and videobronchoscopes. Since hundreds of thousands of CT scans (cost: $600 each)
and bronchoscopies (cost: $1,500) are done yearly, our proposed system has considerable
market potential. It could conceivably marke rapid, accurate, in-depth 3D CT scan reading
feasible and permit the construction of detailed bronchoscopy treatment plans. This can
improve early detection and reduce the cost of lung-cancer management.
Effective start/end date6/28/015/30/02


  • National Cancer Institute: $99,905.00


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.